CW107-3 Study Guide

12345678910111213141516171819
Across
  1. 2. Supplemental insurance plan provided through private insurance companies helping to cover costs not reimbursed by Medicare (Slide 15)
  2. 4. Bringing items with the earliest expiration ate to the front so they are used 1st (Slide 61)
  3. 5. True/False: Tech receives a class-II drug recall from manufacturer. They should check the inventory for recalled lots, and send recall back to manufacturer (Slide 60)
  4. 9. Storage condition: 35.6 to 41 degrees Fahrenheit is considered ______ (Slide 56)
  5. 14. Third-party prior authorization will be denied on all ______, unless justification approved by insurance company
  6. 15. Type of drug formulary that may limit drugs to specific physicians, pt care areas, or disease states (Slide 6)
  7. 16. True/False: The money in a flexible spending account is there for as long as the person needs (Slide 41)
  8. 18. Workersʻ compensation is paid for by ________ (Slide 21)
  9. 19. Insurance for active military members, their families, and retirees (Slide 20)
Down
  1. 1. When ordered item is not currently in stock, but will be sent ASAP (Slide 46)
  2. 3. Medicare ______ __ helps pay for doctorsʻ visits, outpatient care, PT, and medical equipment (Slide 17)
  3. 6. The term third-party billing refers to the portion of payment _____ by insurance companies (Slide 24)
  4. 7. True/False: A P&T Committee is responsible for medication use evaluation, and/or hospital drug formulary changes, and creating policies regarding adverse interaction monitoring (Slide 6)
  5. 8. Medicare ______ __ helps pay for RX medicine, diabetic insulin & syringes (Slide 17!)
  6. 10. The amount to be charged to pt for a Rx is decided by the _______ ______
  7. 11. NOT a government-managed program (Slide 12)
  8. 12. True/False: The NDC and Lot #ʻs are needed in order to pull a drug recall from the shelf (Slide 17)
  9. 13. Computerized dispensing units that automatically tracks inventory (Slide 52)
  10. 17. Insurance plan requiring a PCP (Slide 10)